JP2005047929A5 - - Google Patents

Info

Publication number

JP2005047929A5

JP2005047929A5 JP2004273531A JP2004273531A JP2005047929A5 JP 2005047929 A5 JP2005047929 A5 JP 2005047929A5 JP 2004273531 A JP2004273531 A JP 2004273531A JP 2004273531 A JP2004273531 A JP 2004273531A JP 2005047929 A5 JP2005047929 A5 JP 2005047929A5

Authority

JP

Japan

Prior art keywords

use according

dextrin

composition

body cavity

amount

Prior art date

2004-09-21

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 229920001353 Dextrin Polymers 0.000 claims 22
• 239000004375 Dextrin Substances 0.000 claims 22
• 235000019425 dextrin Nutrition 0.000 claims 22
• 239000000203 mixture Substances 0.000 claims 19
• QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims 3
• 239000011230 binding agent Substances 0.000 claims 2
• 150000001875 compounds Chemical class 0.000 claims 2
• 239000000314 lubricant Substances 0.000 claims 2
• 210000003200 peritoneal cavity Anatomy 0.000 claims 2
• 229920000642 polymer Polymers 0.000 claims 2
• 238000006116 polymerization reaction Methods 0.000 claims 2
• WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 claims 1
• RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 claims 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims 1
• 102000005701 Calcium-Binding Proteins Human genes 0.000 claims 1
• 108010045403 Calcium-Binding Proteins Proteins 0.000 claims 1
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical group OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims 1
• 102000009123 Fibrin Human genes 0.000 claims 1
• 108010073385 Fibrin Proteins 0.000 claims 1
• BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims 1
• 229920002683 Glycosaminoglycan Polymers 0.000 claims 1
• 239000000853 adhesive Substances 0.000 claims 1
• 230000001070 adhesive effect Effects 0.000 claims 1
• 239000003242 anti bacterial agent Substances 0.000 claims 1
• 239000002260 anti-inflammatory agent Substances 0.000 claims 1
• 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
• 229940088710 antibiotic agent Drugs 0.000 claims 1
• 239000013011 aqueous formulation Substances 0.000 claims 1
• 239000011575 calcium Substances 0.000 claims 1
• 229910052791 calcium Inorganic materials 0.000 claims 1
• 239000003814 drug Substances 0.000 claims 1
• KAQKFAOMNZTLHT-VVUHWYTRSA-N epoprostenol Chemical compound O1C(=CCCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-VVUHWYTRSA-N 0.000 claims 1
• 229960001123 epoprostenol Drugs 0.000 claims 1
• 229950003499 fibrin Drugs 0.000 claims 1
• 239000003527 fibrinolytic agent Substances 0.000 claims 1
• 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 1
• 150000004676 glycans Chemical class 0.000 claims 1
• 229940014041 hyaluronate Drugs 0.000 claims 1
• 238000002386 leaching Methods 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 claims 1
• 229960000907 methylthioninium chloride Drugs 0.000 claims 1
• 230000007935 neutral effect Effects 0.000 claims 1
• 150000003904 phospholipids Chemical group 0.000 claims 1
• 229920001282 polysaccharide Polymers 0.000 claims 1
• 239000005017 polysaccharide Substances 0.000 claims 1
• 238000002360 preparation method Methods 0.000 claims 1
• 125000001453 quaternary ammonium group Chemical group 0.000 claims 1
• 230000008929 regeneration Effects 0.000 claims 1
• 238000011069 regeneration method Methods 0.000 claims 1
• NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims 1
• 239000001509 sodium citrate Substances 0.000 claims 1
• 239000000243 solution Substances 0.000 claims 1